Live feed08:00:00·1984dPRReleasevia QuantisnowMinerva Neurosciences and Royalty Pharma Announce Sale of Seltorexant Royalty for up to $155 MillionByQuantisnow·Wall Street's wire, on your screen.NERV· Minerva Neurosciences IncRPRX· Royalty Pharma plcHealth CareOriginal source
